Profile: Enterix Inc. is a biotechnology company that manufactures, markets, and distributes products for colorectal cancer screening. We also use this product to provide a colorectal cancer screening service. We offer insure quik FIT fecal immunochemical test, that provides physicians with the sensitivity and specificity of the laboratory-based InSure FIT test. The availability of the CLIA-waived insure quik FIT test is intended to help physicians increase patient compliance with an annual colorectal cancer screening test. InSure quik FIT test uses the same patient-friendly blue brush collection method as the InSure FIT and is considered equivalent to the InSure FIT test. FIT tests detect blood in the stool that might indicate colorectal cancer or other lower gastrointestinal diseases & tests help identify individuals that are candidates for colonoscopy, even if they do not have overt symptoms of colorectal cancer & this may trace the disease in its early treatable stages, or that they may have precancerous polyps that can be removed during colonoscopy.

The company was founded in 1997.

FDA Registration Number: 1226769